Literature DB >> 30139458

Hypokalemic Distal Renal Tubular Acidosis.

Patricia G Vallés1, Daniel Batlle2.   

Abstract

Distal renal tubular acidosis (DRTA) is defined as hyperchloremic, non-anion gap metabolic acidosis with impaired urinary acid excretion in the presence of a normal or moderately reduced glomerular filtration rate. Failure in urinary acid excretion results from reduced H+ secretion by intercalated cells in the distal nephron. This results in decreased excretion of NH4+ and other acids collectively referred as titratable acids while urine pH is typically above 5.5 in the face of systemic acidosis. The clinical phenotype in patients with DRTA is characterized by stunted growth with bone abnormalities in children as well as nephrocalcinosis and nephrolithiasis that develop as the consequence of hypercalciuria, hypocitraturia, and relatively alkaline urine. Hypokalemia is a striking finding that accounts for muscle weakness and requires continued treatment together with alkali-based therapies. This review will focus on the mechanisms responsible for impaired acid excretion and urinary potassium wastage, the clinical features, and diagnostic approaches of hypokalemic DRTA, both inherited and acquired.
Copyright © 2018 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acid excretion; Distal RTA; Growth failure; Hyperchloremic metabolic acidosis; Hypokalemia

Mesh:

Substances:

Year:  2018        PMID: 30139458     DOI: 10.1053/j.ackd.2018.05.003

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  14 in total

1.  Single-cell RNA profiling of glomerular cells in diabetic kidney: a step forward for understanding diabetic nephropathy.

Authors:  María José Soler; Daniel Batlle
Journal:  Ann Transl Med       Date:  2019-12

Review 2.  Distal renal tubular acidosis: genetic causes and management.

Authors:  Sílvia Bouissou Morais Soares; Luiz Alberto Wanderley de Menezes Silva; Flávia Cristina de Carvalho Mrad; Ana Cristina Simões E Silva
Journal:  World J Pediatr       Date:  2019-05-11       Impact factor: 2.764

Review 3.  Long-term complications of primary distal renal tubular acidosis.

Authors:  Fernando Santos; Helena Gil-Peña
Journal:  Pediatr Nephrol       Date:  2022-05-11       Impact factor: 3.714

4.  Determinants and Outcomes Associated With Urinary Calcium Excretion in Chronic Kidney Disease.

Authors:  Jing Liu; Maria Clarissa Tio; Ashish Verma; Insa M Schmidt; Titilayo O Ilori; Felix Knauf; Finnian R Mc Causland; Sushrut S Waikar
Journal:  J Clin Endocrinol Metab       Date:  2022-01-01       Impact factor: 6.134

5.  Long-Standing Hypokalemia and Lactic Acidosis as the Primary Presentation of Mitochondrial Myopathy.

Authors:  Jing Miao; Qi Qian; Ladan Zand
Journal:  Kidney Int Rep       Date:  2020-02-05

Review 6.  Role of Citrate in Pathophysiology and Medical Management of Bone Diseases.

Authors:  Donatella Granchi; Nicola Baldini; Fabio Massimo Ulivieri; Renata Caudarella
Journal:  Nutrients       Date:  2019-10-25       Impact factor: 5.717

7.  Severe Hypokalemia Secondary to Transient Distal Renal Tubular Acidosis in a Previously Healthy Woman.

Authors:  Efthymia Kallistrou; Nalini N Architha; Soubhik K Pal; Samson O Oyibo
Journal:  Cureus       Date:  2021-01-18

8.  Clinical and Biochemical Characteristics of Patients with Renal Tubular Acidosis in Southern Part of West Bengal, India: A Retrospective Study.

Authors:  Partha Pratim Chakraborty; Rana Bhattacharjee; Shinjan Patra; Ajitesh Roy; Kripasindhu Gantait; Subhankar Chowdhury
Journal:  Indian J Endocrinol Metab       Date:  2021-09-08

9.  Propylene glycol neurotoxicity due to sodium citrate therapy in an infant with renal tubular acidosis.

Authors:  Mahjabeen Khan; Ara Vartanyan; Anthony Scalzo; Sarah Riley; Jeanine Cain; Joseph Maliakkal
Journal:  Clin Nephrol Case Stud       Date:  2020-05-08

Review 10.  Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome.

Authors:  Giacomo Ramponi; Marco Folci; Salvatore Badalamenti; Claudio Angelini; Enrico Brunetta
Journal:  Front Immunol       Date:  2020-09-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.